⌘K

Home/Filings/4/0001493152-22-035280

4//SEC Filing

Bernards Rene 4

Accession 0001493152-22-035280

CIK 0001335105other

View on SEC.gov Company Profile

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 11:44 AM ET

Size

4.4 KB

Accession

0001493152-22-035280

Insider Transaction Report

Form 4

Period: 2022-12-12

LIXTE BIOTECHNOLOGY HOLDINGS, INC.LIXT

Director

Transactions

Purchase
Common Stock
2022-12-12$0.61/sh+10,000$6,100→ 135,000 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

CIK 0001335105

Entity typeother

Related Parties

1

filerCIK 0001939159

Filing Metadata

Form type: 4
Filed: Dec 12, 7:00 PM ET
Accepted: Dec 13, 11:44 AM ET
Size: 4.4 KB

View on SEC.gov